Skip to content
DraconiticResearch
Search Sources API
194,216 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BYCureus

Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report

  • Takayuki Ota1
  • Shoji Iinuma2
  • Yosuke Suyama1
  1. 1Gastroenterology, Rakuwakai Marutamachi Hospital, Kyoto, JPN
  2. 2Gastroenterology, Rakuwakai Otowa Hospital, Kyoto, JPN
Read full textPDFCite

Related

  1. Surufatinib and camrelizumab plus nab-paclitaxel–gemcitabine as first-line treatment for metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
    Yudong Yuan, Dongdong Zhang, Yuying Li +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  2. From Choledocholithiasis to Metastatic Pancreatic Adenocarcinoma: A Diagnostic Odyssey Highlighting Missed Red Flags.
    Abdullah Farooq, Jazeela Saud, Henok E Sisay +3
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma
    Adrien Grancher, Leila Tagemouati, André Gillibert +6
    Clinics and Research in Hepatology and GastroenterologyPeer-reviewedCC BY2 citedOncologyHAL
  4. Efficacy and Safety of Daraxonrasib (RMC-6236) in Previously Treated Metastatic RAS-Mutated Pancreatic Ductal Adenocarcinoma: A Systematic Review.
    Natalia Gierulska, Nina Jankowska, Zuzanna Dąbrowska +2
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Case Report: Metastatic duodenal hepatoid adenocarcinoma: a rare pathology with exceptional response to dual immune checkpoint blockade
    Ranju Gupta, Darshan Lal, Rohit Walia +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{ota2026exceptionally,
  title = {{Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report}},
  author = {Takayuki Ota and Shoji Iinuma and Yosuke Suyama},
  journal = {Cureus},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13657664},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report
AU  - Takayuki Ota
AU  - Shoji Iinuma
AU  - Yosuke Suyama
PY  - 2026
DA  - 2026/10/16
JO  - Cureus
UR  - https://europepmc.org/article/PMC/PMC13657664
SN  - 2168-8184
ER  -